Fidelity Disruptive Medicine ETF
FMED
9 hedge funds and large institutions have $31.5M invested in Fidelity Disruptive Medicine ETF in 2023 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 1 reducing their positions, and 1 closing their positions.
300% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 1
200% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 1
29% more funds holding
Funds holding: 7 → 9 (+2)
13% more capital invested
Capital invested by funds: $27.9M → $31.5M (+$3.63M)
1.94% more ownership
Funds ownership: 59.41% → 61.35% (+1.9%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
+$1.72M |
| 2 |
Wealth Enhancement Advisory Services
Plymouth,
Minnesota
|
+$33.2K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$10.4K |
| 4 |
ASN
Advisory Services Network
Atlanta,
Georgia
|
+$2.39K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$1.08K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VF
Virtu Financial
New York
|
-$493K |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$392K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Fidelity Investments
Boston,
Massachusetts
| $17.4M | -$392K | -18,061 | -2% |
|
|
2
Wealth Enhancement Advisory Services
Plymouth,
Minnesota
| $11.3M | +$33.2K | +1,532 | +0.3% |
|
|
3
Jane Street
New York
| $2.72M | +$1.72M | +79,246 | +240% |
|
|
4
UBS Group
Zurich,
Switzerland
| $14.4K | +$10.4K | +478 | +405% |
|
|
TRCT
5
Tower Research Capital (TRC)
New York
| $3.92K | +$1.08K | +50 | +45% |
|
|
ASN
6
Advisory Services Network
Atlanta,
Georgia
| $2.66K | +$2.39K | +110 | New |
|
|
DF
7
Dunhill Financial
London,
United Kingdom
| $1.51K | +$781 | +36 | New |
|
|
HI
8
Harbour Investments
Madison,
Wisconsin
| $993 | – | – | – |
|
9
Morgan Stanley
New York
| $436 | +$391 | +18 | New |
|
|
VF
10
Virtu Financial
New York
| – | -$493K | -22,261 | Closed |
|
FMED Hedge Fund Activity: Q4 2023 in Review
9 of the 6,860 institutional investors tracked by Wall St. Rank reported a position in Fidelity Disruptive Medicine ETF (FMED) for Q4 2023, worth a combined $31.5M — up 13% from $27.9M a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new FMED positions and 1 closed out — a net gain of 2 holders — while 4 added to existing stakes and 1 trimmed.
The largest buyer was Jane Street, adding an estimated $1.72M. The largest seller was Virtu Financial, exiting entirely with an estimated $493K sold.
- 9 institutional investors held Fidelity Disruptive Medicine ETF (FMED) as of Q4 2023, up from 7 in Q3 2023.
- Funds reported $31.5M of Fidelity Disruptive Medicine ETF stock for Q4 2023, up 13% quarter-over-quarter.
- 3 funds opened new Fidelity Disruptive Medicine ETF positions in Q4 2023 and 1 closed out, a net change of +2 holders.
- The largest Fidelity Disruptive Medicine ETF buyer in Q4 2023 was Jane Street, an estimated $1.72M added.
- The largest Fidelity Disruptive Medicine ETF seller in Q4 2023 was Virtu Financial, an estimated $493K sold.
Based on aggregated 13F filings for Q4 2023.